In recent years, investors have been steadily pouring billions into exchange-traded funds (ETFs). The appeal of investing in an industry or thematic style is a simpler approach than stock-picking for many investors.
Yet there are still many investors looking for the most appealing stocks in any given sector. But finding the right stock can be tricky if they all seem to be similarly valued or all are poised to profit from the same trend.
I was thinking about this topic recently as I checked in with the nation's leading auto suppliers. Four months ago, I noted that all of the major companies in this industry were capable of robust share buybacks, thanks to their prodigious cash flow.
It's a theme that has surely resonated with other investor as well, as each of these stocks has since outperformed the S&P 500.
Top Promising Companies To Watch For 2015: Medbox Inc (MDBX.PK)
Medbox Inc. (Medbox) offers a machine that dispenses medication to individuals based on biometric identification (fingerprint sample). The machine allows pharmacies, hospitals, doctors' offices, and alternative medicine clinics to manage employee possession of sensitive drugs. The system also allows these clinics to demonstrate that the user visiting the machine is a registered patient and that the patient has a valid and unexpired authorization from a physician to possess and use the medicine dispensed. The Company has national and international presence with offices in Los Angeles, New York, Toronto, London and Tokyo.
Medbox, through its subsidiaries, offers consulting services to the alternative medicine industry, as well as to the mini self-storage market. The Company provides consulting services primarily to individuals and groups seeking to establish new clinics and facilities, often in jurisdictions that have recently passed legislation concerning th e availability of alternative medicines, as well as existing jurisdictions, nationwide.
Advisors' Opinion:- [By Alan Brochstein]
Taking into account all of the data I have shared, I want to introduce my take on the most important names to follow. My initial list takes into account not only the market cap, but also business model and interest level. These are the stocks that I think merit the most attention (in alphabetical order):
CannaVest (CANV.OB)GW Pharma (GWPH)MedBox (MDBX.PK)Medical Marijuana, Inc. (MJNA.PK)CANV doesn't really trade, as it is held closely by insiders (99.7%, including MJNA). I have a few concerns, including the valuation and some near-term financial challenges typical of a start-up with just one client looking to expand its customer base, but I like the focus and the fact that it is an SEC filer with a relatively clean history (i.e. none of the baggage of some of these other companies). I have spoken to its outsourced CFO and am impressed by his background (has been CFO or held key financial roles at publicly-traded healthcare companies). CANV is the partner to MJNA that is responsible for manufacturing the CBD (Cannibidiol, the cannabinoid in marijuana that is increasingly viewed as offering substantial medical benefits). I am very concerned about the near-term financials, but this is a pure-play with probably a two-year lead over other companies. I don't see a moat in terms of intellectual property or brands, but they have a good lead in terms of sourcing of supply and penetration into potential customers. Quite simply, they don't appear to have competition at present. The company, then, is a call option on CBD demand taking off. It appears that it could be a supplier to even Big Pharma should medical marijuana research move into the mainstream.
Top Forestry Stocks To Invest In 2014: TherapeuticsMD Inc (TXMD)
TherapeuticsMD, Inc., incorporated in 1907, promotes, distributes and sells certain products developed and sold by Spectrum Health Network, Inc. (Spectrum) relative to its digital media network. Through the license agreement, the Company focuses on multispecialty group practices and independent physician associations (IPAs) to sell them subscriptions for software, hardware and content developed for and distributed by Spectrum. Spectrum sells its network to IPAs for equipment and installation. On October 4, 2011, the Company acquired VitaMedMD, LLC (VitaMedMD). As a result of the acquisition, VitaMedMD became a wholly owned subsidiary of the Company.
VitaMedMD is a specialty pharmaceutical company, VitaMed is focused on providing products to the women�� health market. The Company focuses on market both over-the-counter (OTC) and prescription nutritional supplements, drugs, medical foods and other medical products through pharmacies and its Web-site. Its brand includes a range of products for women�� health and associated with pregnancy, child birth, nursing, post birth and menopause. Its OTC product line available through its Website includes prenatal vitamins, DHA, iron supplements, calcium supplements, Vitamin D supplements, women�� multivitamins, natural (non-hormonal) menopause relief, and scar reduction creams. In March 2012, the Company launched its first prescription-only prenatal vitamin, vitaMedMD Plus Rx.
vitaMedMD Plus Prenatal Multi-Vitamin + DHA is a two pill combo pack that contains 18 essential vitamins and minerals and 300 milligrams (mg) of life�� DHA. vitaMedMD is a single dose daily multivitamin that provides 14 vitamins, minerals and 200 mg of vegetarian, plant-pure life�� DHA. vitaMedMD Plus Rx is a product with a single-dose combo-pack containing one prenatal vitamin tablet with Quatrefolic Acid. vitaMedMD Plus Rx is a product with a single-dose daily multivitamin containing Quatrefolic Acid. vitaMedMD Iron-150 is a iron replacement supplement. ! vitaMedMD Menopause Relief with Lifenol Plus Bone Support offers a natural solution for hot flashes, night sweats and mood disturbances. vitaMedMD Calcium + Vitamin D is a dietary supplements that help replenish and maintain beneficial levels of Vitamin D. vitaMedMD Stretch Mark Body Cream contains naturally-derived ingredients, including Peptides, Shea Butter, Sweet Almond Oil and Fruit Extracts, that hydrate, soothe and pamper skin to make it softer, smoother and younger-looking.
Advisors' Opinion:- [By John Udovich]
Yesterday, mid cap women�� health stock Hologic, Inc (NASDAQ: HOLX) fell more than 10% after disappointing Wall Street on earnings,�meaning it might be time to take a look at it and�small cap women�� health stocks�The Female Health Company (NASDAQ: FHCO) and TherapeuticsMD Inc (NYSEMKT: TXMD) because after all, women account for half the population and these three small caps are all focused on the women�� health:
Top Forestry Stocks To Invest In 2014: MKS Instruments Inc.(MKSI)
MKS Instruments, Inc., together with its subsidiaries, provides instruments, subsystems, and process control solutions that measure, control, power, monitor, and analyze parameters of manufacturing processes worldwide. It offers instruments and control systems, such as pressure measurement and control, materials delivery, gas composition analysis, and control and information technology products. The company also provides power and reactive gas generation products comprising power delivery, reactive gas generation, processing thin films, and equipment cleaning products; and vacuum technology products, including vacuum containment components, vacuum gauges, vacuum valves, effluent management subsystems and custom stainless steel chambers, vessels, and pharmaceutical process equipment hardware and housings. Its products are used in the semiconductor processing steps, such as depositing thin films of material onto silicon wafer substrates, and etching and cleaning circuit patt erns; manufacture of flat panel displays, light emitting diodes, solar cells, data storage media, and other coatings, including architectural glass; energy generation and environmental monitoring processes, such as nuclear fuel processing, fuel cell research, greenhouse gas monitoring, and chemical agent detection; medical instrument sterilization; consumable medical supply manufacturing; and pharmaceutical applications. The company also offers maintenance and repair, software maintenance, installation, and training services. It serves semiconductor capital equipment and device manufacturers, thin film capital equipment manufacturers, energy generation, environmental monitoring, and manufacturing companies, as well as government, university and industrial research laboratories. The company sells its products primarily through its direct sales force, as well as through sales representatives and agents. MKS Instruments, Inc. was founded in 1961 and is headquartered in Andover, Massachusetts.
Advisors' Opinion:- [By Ben Axler]
In the table below, we've listed a sample of small-cap semiconductor capital equipment stocks such as Entegris (ENTG), Advanced Energy Industries (AEIS), ATMI Inc. (ATMI), MKS Instruments (MKSI), Photronics Inc. (PLAB), Rudolph Technologies (RTEC),FormFactor (FORM) and Mattson Technology (MTSN). The peers trade at approximately 1.0x and 15.5x 2014E revenues and EPS, respectively. Furthermore, the average peer trades at 2.1x tangible book value. However, these multiples are based on average 2014E industry revenue and earnings growth of 18% and 119%, respectively. Axcelis is poised to grow at a rate substantially above the industry average.
- [By James E. Brumley]
What do small cap stocks MKS Instruments, Inc. (NASDAQ:MKSI), Tanger Factory Outlet Centers Inc. (NYSE:SKT), and Kaman Corporation (NYSE:KAMN) have in common? Absolutely nothing, on the surface, and no, it's not a setup for painfully bad punchline. There is a common thread among KAMN, SKT, and MKSI right now, however... they're all three going into my mental (though publicly-tracked) portfolio this afternoon.
Top Forestry Stocks To Invest In 2014: Empire State Realty Trust Inc (ESRT)
Empire State Realty Trust, Inc., incorporated on July 29, 2011, is a self-administered and self-managed real estate investment trust (REIT), which owns, manages, operates, acquires and repositions office and retail properties in Manhattan and the greater New York metropolitan area. The Company operates in two segments: real estate and construction contracting. As of June 30, 2013, the Company owned 12 office properties (including one long-term ground leasehold interest) encompassing approximately 7.7 million rentable square feet of office space, which were approximately 83.5% leased (or 86.2% giving effect to leases signed but not yet commenced as of that date). Seven of these properties are located in the midtown Manhattan market and encompass in the aggregate approximately 5.9 million rentable square feet of office space, including the Empire State Building. Its Manhattan office properties also contain an aggregate of 440,615 rentable square feet of retail space on their ground floor and/or lower levels. Its remaining five office properties are located in Fairfield County, Connecticut and Westchester County, New York, encompassing in the aggregate approximately 1.8 million rentable square feet.
The Company has entitled land at the Stamford Transportation Center in Stamford, Connecticut, adjacent to one of its office properties, that supports the development of an approximately 380,000 rentable square foot office building and garage, which refers to herein as Metro Tower. As of June 30, 2013, its portfolio also included four standalone retail properties located in Manhattan and two standalone retail properties located in the city center of Westport, Connecticut, encompassing 204,452 rentable square feet in the aggregate. As of June 30, 2013, its standalone retail properties were 100% leased in the aggregate. In addition, the Company has an option to acquire from affiliates of its predecessor two additional Manhattan office properties encompassing approximately 1.5 million rentable squar! e feet of office space and 153,209 rentable square feet of retail space at the base of the buildings.
The Empire State Building is the Company�� flagship property. The 102-story building consists of 2,701,938 rentable square feet of office space and 167,788 rentable square feet of retail space. The building also includes its observatory and broadcasting operations. The Company�� portfolio includes retail properties located in retail corridors in Manhattan and Westport, Connecticut. Tenants at 10 Union Square in Manhattan include Best Buy Mobile, Starbucks, A&P, Panera Bread, FedEx/Kinko��, Au Bon Pain, Chipotle Mexican Grill, and GameStop. In the greater New York metropolitan area, its portfolio includes high quality suburban office properties in densely populated metropolitan communities in Fairfield County, Connecticut and Westchester County, New York. tenants of the greater New York metropolitan area flagship Metro Center (at the Transportation Center in Stamford, Connecticut) include Thomson Reuters, Jefferies Group, Columbus Circle Investors, Torm Shipping, Olympus Partners, BP Energy, Tweedy, Browne Company and Susquehanna International.
The Company approximately has 242 million square feet of rentable space, which are contained within Midtown�� multi-tenant office buildings. Downtown Chicago and the Washington, D.C. CBD combine has a total of 230 million square feet of office space. Three-quarters 75.3% of Midtown�� office stock is classified as Class A with total square footage of 182 million square feet. The Company approximately has 43.9 million square feet of Midtown office space is counted as Class B stock, accounting for 18.2% of the total market. The remaining 6.5% of Midtown office space (15.8 million square feet) is categorized as Class C space. The Grand Central submarket is a office submarket in Midtown Manhattan with 44 million square feet and is located on the east side of Midtown Manhattan, to the north of Murray Hill and to the south of the Park ! Avenue co! rridor.
The West Side office submarket, located to the south and west of Central Park and including the area around Columbus Circle, consists of 25.8 million square feet of office space. Westchester County contains approximately 28.9 million square feet of office space and is split into six submarkets: White Plains CBD and non-CBD, Northern, Central, Eastern and Southern. The White Plains CBD is situated in south central Westchester County, along the Cross-Westchester Expressway (Interstate 287) corridor between the Sprain Brook Parkway and the Hutchinson River Parkway. The submarket consists of approximately 6.3 million square feet of office space and is defined to include the area south of Barker Avenue, north of Quinby Avenue, east of the Bronx River Parkway and west of South Broadway/Post Road. Westchester�� Eastern office submarket consists of 6.5 million square feet of space and is located to the east of White Plains, between New Rochelle and the Connecticut state border.
Advisors' Opinion:- [By Jonas Elmerraji]
We're seeing a similar setup in shares of Empire State Realty Trust (ESRT), the $1.5 billion commercial landlord that counts Manhattan's Empire State Building among its 7.7 million leasable square feet of office space. ESRT is a relative newcomer to the public markets, trading for the first time back in October.
But just like PEB, Empire State is forming an ascending triangle setup -- in this case, with the resistance level to watch at $15.50. In fact, that $15.50 level has acted like a ceiling for shares five times now since last December; each of those times, shares have gotten swatted lower. That means that a breakout above $15.50 is a materially significant buy trigger.
When $15.50 does get taken out, I'd recommend keeping a protective stop at the 50-day moving average. That level has been a good proxy for ESRT's support line over the course of the whole pattern.
- [By Reuters]
John Moore/Getty Images NEW YORK -- Investors in the Empire State Building have filed a lawsuit accusing the real estate magnates who took it public of short-changing them $300 million by refusing to sell the iconic skyscraper at a premium price. According to a complaint filed Tuesday in a New York state court in Manhattan, Peter Malkin and his son Anthony put their own interests ahead of the building's investors by spurning all-cash offers of as much as $2.3 billion for the building and $1.4 billion for Empire State Building Associates, which held the title and master lease. Instead, the Malkins put the landmark building and 17 other properties into Empire State Realty Trust Inc., whose Oct. 1 IPO valued the property at just $1.89 billion and ESBA at just $1.1 billion, according to the complaint. The lawsuit by plaintiff Marc Postelnek seeks class-action status on behalf of more than 2,800 investors who hold shares in ESBA, which was created in 1961 and was supervised by a Malkin company, Malkin Holdings. It claimed the Malkins acted in bad faith by aborting a "bidding war" for the building, and instead enriched themselves by hundreds of millions of dollars through an IPO. "Given their positions of control and authority over the fate of the Empire State Building, the Malkins had a duty to act in the best interests of their investors," the plaintiffs' lawyer, John Rizio-Hamilton, a partner at Bernstein Litowitz Berger & Grossmann, representing Postelnek, told Reuters. "By failing to properly consider offers to maximize the building's value, the Malkins breached that duty." The lawsuit seeks to recover profit that building investors allegedly lost because of the Malkins' refusal to sell. Empire State Realty Trust, a real estate investment trust, is a successor to Malkin Holdings. "These claims are wholly without merit and we will respond to them in court," a spokeswoman for the REIT said Thursday. ESBA had been created by Lawrence Wien, the father
Top Forestry Stocks To Invest In 2014: Enzon Pharmaceuticals Inc. (ENZN)
Enzon Pharmaceuticals, Inc., a biotechnology company, engages in the research and development of therapeutics for cancer patients with unmet medical needs. The company?s drug-development programs utilize two platforms-Customized PEGylation Linker Technology and third-generation mRNA-targeting agents utilizing the Locked Nucleic Acid (LNA) technology. It currently holds four compounds in clinical development and multiple novel LNA targets in preclinical research. The company?s development product pipeline consists of PEG-SN38 compound that utilizes Customized Linker Technology, which is in Phase II clinical trials for the treatment of metastatic colorectal and breast cancer, as well as a Phase I trial for pediatric patients with cancer; and the Hypoxia-Inducible Factor-1 alpha antagonist in Phase I studies for the treatment of solid tumors and lymphoma. Its product line also comprises Survivin antagonist in Phase I study in pediatric patients with recurrent acute lymphoblas tic leukemia; Androgen Receptor antagonist, a validated target for the treatment of prostate cancer that is in a Phase I study in patients with castration-resistant prostate cancer; and rights to five compounds, including AR, HER3, beta-catenin, PI3KCA, and Gli2. Enzon Pharmaceuticals, Inc. was founded in 1981 and is headquartered in Piscataway, New Jersey.
Advisors' Opinion:- [By Lisa Levin]
Enzon Pharmaceuticals (NASDAQ: ENZN) shares fell 2.57% to touch a new 52-week low of $1.11. Enzon Pharmaceuticals shares have dropped 75.85% over the past 52 weeks, while the S&P 500 index has gained 24.92% in the same period.
- [By Lisa Levin]
Enzon Pharmaceuticals (NASDAQ: ENZN) shares tumbled 28.28% to reach a new 52-week low of $1.15. Enzon Pharmaceuticals shares have dropped 63.30% over the past 52 weeks, while the S&P 500 index has gained 28.75% in the same period.
- [By Monica Wolfe]
Over the past week Seth Klarman (Trades, Portfolio) of The Baupost Group made one real time reduction; the guru reduced his holdings in Enzon Pharmaceutical (ENZN).� The guru cut his holdings in the company -43.6% by selling 3,353,595 shares of the company�� stock.� He sold these shares at an average price of $1.15 per share; the shares are still currently trading at around the same price.
Top Forestry Stocks To Invest In 2014: Xyratex Ltd.(XRTX)
Xyratex Ltd provides modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. It offers enterprise data storage solutions that include storage enclosures, which provide a common technology platform that reduces qualification time for original equipment manufacturer (OEM) customers and includes management interface software, standardized across enclosures, and provides easy integration as new platforms; integrated application platforms that comprise embedded storage platforms, which incorporate embedded server modules into its storage enclosures; and HPC Solutions that consolidate controllers, storage enclosures, application platforms, operating system, data protection, Lustre File System, and management software into a optimized scale-out storage platform that can be deployed in hours rather than weeks. The company also designs and manufactures a range of process test systems, which incorporate mechanical and electronic hardware, and firmware for controlling the HDD operating environment during the formatting of the disk drive. In addition, it provides automated solutions comprising substrate and media inspection systems; servo track writers and related subassemblies; and head testing systems that test and process HDD components throughout the manufacturing process. The company markets and sells its products primarily to OEMs and disk drive manufacturers, as well as to other companies in North America, Asia, and Europe. Xyratex Ltd was founded in 1966 and is headquartered in Havant, the United Kingdom.
Advisors' Opinion:- [By Patricio Kehoe]
According to GuruFocus Real Time Picks, on March 7, Mario Gabelli (Trades, Portfolio), the chairman and chief executive officer of GAMCO Investors Inc. added Xyratex Ltd. (XRTX) at an average price of $13.17 and currently holds 742,642 shares of the stock, worth 0.05% of his portfolio.
- [By Sue Chang and William L. Watts]
Xyratex Ltd. (XRTX) �dropped 6.7%. The company late Thursday reported a 70% drop in third-quarter earnings and offered a somewhat downbeat fourth-quarter forecast. The U.K.-based maker of data-storage and manufacturing equipment said it expects fourth-quarter results to range between a loss of four cents and a profit of 20 cents on revenue of $190 million to $220 million. Analysts surveyed by Thomson Reuters had produced a forecast for profit of 16 cents on revenue of $218 million. Shares are up by around 43% for the year to date.
No comments:
Post a Comment